ADRX

About ADRX

ADRx Pharma is a biotechnology company focused on developing and commercializing novel therapies to prevent the abnormal aggregation of proteins that cause amyloid diseases. The company serves the healthcare market, particularly targeting conditions like Alzheimer's and other neurodegenerative diseases. ADRx employs a proprietary universal platform called ADvantage, which integrates multiple drug discovery strategies. This platform starts with a detailed structural analysis of each target protein or peptide and utilizes both computational and empirical screening tools to design effective molecular inhibitors. The business model revolves around drug discovery and development, with revenue generated through the commercialization of these novel therapies. ADRx's clients include healthcare providers, research institutions, and pharmaceutical companies. The company operates in the biotechnology and pharmaceutical sectors, leveraging cutting-edge technology to address unmet medical needs.